射频消融治疗后超声造影与治疗前增强CT/MRI融合成像评估肝癌消融安全边距
纳入34例患者47个肝癌病灶,RFA后1-3天用治疗后CEUS与治疗前CECT/CEMRI融合成像评估消融安全边距,CEUS-CECT/CEMRI融合显示47个(100%)消融区,优于US融合36个(76.6%)和常规US 21个(44.7%)(均p<0.001);安全边距不足与局部肿瘤进展相关(1/4 vs 1/43,p<0.001)。
要点
- CEUS-CECT/CEMRI融合成像可清晰显示全部47个消融区,优于US融合(76.6%)和常规US(44.7%)。
- 消融安全边距≥5 mm者28个、0-5 mm者15个、<0 mm者4个。
- 安全边距不足在局部肿瘤进展病灶中更常见(1/4 vs 1/43,p<0.001)。
核心结论
- 治疗后CEUS与治疗前CECT/CEMRI融合成像能准确显示RFA后的消融安全边距。
- 消融安全边距不足与局部肿瘤进展相关。
- 作者认为消融后融合成像描绘消融安全边距可考虑作为评估RFA治疗反应的常规程序,并建议将其作为肝癌RFA后的常规程序。
研究设计与样本
- 单臂观察性研究,连续纳入34例患者共47个肝癌病灶,均行经皮超声引导下射频消融(RFA)。
- RFA后1-3天行治疗后CEUS与治疗前CECT/CEMRI融合成像评估局部治疗反应和消融安全边距。
- 以RFA后1个月CECT/CEMRI结果为参考计算完全缓解率,并记录局部肿瘤进展;随访2至34个月。
关键影像表现/征象
- 47个消融区中,CEUS-CECT/CEMRI融合成像清晰显示47个(100%),US-CECT/CEMRI融合成像显示36个(76.6%),常规US显示21个(44.7%),两者与CEUS-CECT/CEMRI融合比较均p<0.001。
- 消融安全边距≥5 mm者28个消融区,0-5 mm者15个,<0 mm者4个。
- 4个安全边距不足的病灶中,3个因CEUS显示消融区大于治疗前病灶而转随访,另1个在首次RFA后5天接受补充RFA。
诊断标准与关键数值
- 以RFA后1个月CECT/CEMRI结果为参考,完全缓解率为95.7%(45/47)。
- 消融安全边距分为≥5 mm(28个)、0-5 mm(15个)和<0 mm(4个)。
- 随访2至34个月,45个完全缓解病灶中2个(4.4%)出现局部肿瘤进展。
- 安全边距不足在局部肿瘤进展病灶中更常见(1/4 vs 1/43,p<0.001)。
临床应用与阅片要点
- 治疗后CEUS与治疗前CECT/CEMRI融合成像可在RFA后早期清晰显示消融区并评估消融安全边距。
- 作者建议将消融后融合成像描绘消融安全边距作为肝癌RFA后的常规程序。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the value of fusion imaging with post-treatment contrast-enhanced ultrasound (CEUS) and pre-treatment contrast-enhanced CT/MRI (CECT/CEMRI) in evaluating ablative safety margin after percutaneous ultrasound (US)-guided radiofrequency ablation (RFA) for liver cancers.
METHODS: 34 consecutive patients with 47 liver lesions who had undergone RFA were included. Fusion imaging with post-treatment CEUS and pre-treatment CECT/CEMRI was carried out to evaluate local treatment response and ablative safety margin within 1-3 days after RFA. The minimal ablative safety margins of the ablation zones were recorded. The complete response (CR) rate was calculated with reference to CECT/CEMRI results 1 month after RFA. The local tumour progression (LTP) was also recorded.
RESULTS: Of the 47 ablation zones, 47 (100%) were clearly depicted with CEUS-CECT/CEMRI fusion imaging, 36 (76.6%) with US-CECT/CEMRI fusion imaging and 21 (44.7%) with conventional US (both p < 0.001). The minimal ablative safety margins were great than or equal to 5 mm in 28 ablation zones, between 0 and 5 mm in 15, and less than 0 mm in 4. For the four lesions without enough ablative safety margin, three were referred to follow-up because CEUS showed larger ablation zones than pre-treatment lesions and the remaining lesion was subject to additional RFA 5 days after the first RFA. The CR rate was 95.7% (45/47) with reference to CECT/CEMRI results 1 month after RFA. During 2 to 34 months follow-up, LTP was found in two (4.4%) of 45 lesions with CR. Insufficient ablative safety margin was more commonly found in those lesions with LTP than those without LTP (1/4 vs 1/43, p < 0.001).
CONCLUSION: Fusion imaging with post-treatment CEUS and pre-treatment CECT/CEMRI can depict the ablative safety margin accurately after RFA. Inadequate ablative safety margin is associated with LTP. Depiction of ablative safety margin by fusion imaging after ablation might be considered as a routine procedure to assess the treatment response of RFA. Advances in knowledge: Fusion imaging with post-treatment CEUS and pre-treatment CECT/CEMRI is an effective method to evaluate the ablative safety margin early after RFA. Therefore, it should be recommended to be used as a routine procedure after RFA for liver cancers.
引用
- Bo XW, Xu HX, Guo LH, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol. 2017. PMID: 28749166. doi:10.1259/bjr.20170063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。